Toshiba America Medical Systems has introduced for its line of rotational angiography equipment 3D technology that simultaneously visualizes blood vessels and bone. The technology, dubbed three-dimensional fusion digital subtraction angiography
Toshiba America Medical Systems has introduced for its line of rotational angiography equipment 3D technology that simultaneously visualizes blood vessels and bone. The technology, dubbed three-dimensional fusion digital subtraction angiography (3D-FDSA), is designed to optimize neurovascular disease diagnosis and surgical planning on its Infinix i-series of vascular x-ray systems. The fusion capability combines separate reconstructions of blood vessels and bone structures in a single volumetric representation, illustrating intracranial vascular anomalies in the context of surrounding bone structures. It was developed in conjunction with neuroradiologists at Johns Hopkins University.
Large Study Affirms Safety of Ultrasound Enhancing Agents for Echocardiography
May 16th 2025Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.
BrightHeart Garners Third FDA Clearance for AI-Powered Assessments of Fetal Heart Ultrasound
May 14th 2025The latest FDA 510(k) clearance is for B-Right Views, an AI-enabled device, which provides automated detection of required views necessary for second- and third-trimester fetal heart ultrasound exams.